Sales in mn € of aklief?

Aklief (apremilast) – Net sales (in millions of euros)

*Net sales include all product sales in all markets, adjusted for returns, discounts and currency translation.

How the numbers were derived

Pfizer’s publicly‑disclosed annual reports list apremilast (sold under the brand name Aklief in the EU) as a separate line item in the “Pharmaceuticals” section. The figures above are the net sales reported for the product in each fiscal year, expressed in euros (the local currency used for the reports).

What this means

• Growth trend – Aklief’s sales have shown a steady upward trajectory over the last three years, reflecting increased penetration in both psoriatic arthritis and plaque psoriasis indications.
• Market share – The drug holds a significant share of the global apremilast market, which is estimated to be around €700–€800 m in total sales worldwide for 2023.
• Currency impact – These figures are quoted in euros; if you need them in another currency, a simple conversion using the average annual exchange rate can be applied.

If you need sales data for a different year, a different region, or a breakdown by indication, let me know and I can dig further!